These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12107850)

  • 1. Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo.
    Tunstall RG; Barnett AA; Schofield J; Griffiths J; Vernon DI; Brown SB; Roberts DJ
    Br J Cancer; 2002 Jul; 87(2):246-50. PubMed ID: 12107850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo.
    Abels C; Fritsch C; Bolsen K; Szeimies RM; Ruzicka T; Goerz G; Goetz AE
    J Photochem Photobiol B; 1997 Aug; 40(1):76-83. PubMed ID: 9301046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy.
    Casas A; Battah S; Di Venosa G; Dobbin P; Rodriguez L; Fukuda H; Batlle A; MacRobert AJ
    J Control Release; 2009 Apr; 135(2):136-43. PubMed ID: 19168101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles.
    Casas A; Fukuda H; Batlle AM
    Br J Cancer; 1999 Sep; 81(1):13-8. PubMed ID: 10487606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynamic therapy.
    Di Venosa GM; Casas AG; Battah S; Dobbin P; Fukuda H; Macrobert AJ; Batlle A
    Int J Biochem Cell Biol; 2006 Jan; 38(1):82-91. PubMed ID: 16172016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures.
    Casas A; Perotti C; Saccoliti M; Sacca P; Fukuda H; Batlle AM
    Br J Cancer; 2002 Mar; 86(5):837-42. PubMed ID: 11875750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: an in vitro study.
    Battah S; O'Neill S; Edwards C; Balaratnam S; Dobbin P; MacRobert AJ
    Int J Biochem Cell Biol; 2006; 38(8):1382-92. PubMed ID: 16546435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
    Hua Z; Gibson SL; Foster TH; Hilf R
    Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
    Tsai JC; Chen IH; Wong TW; Lo YL
    Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues.
    Di Venosa G; Batlle A; Fukuda H; Macrobert A; Casas A
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):478-86. PubMed ID: 16485117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
    Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
    Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy.
    Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ
    Mol Cancer Ther; 2008 Jun; 7(6):1720-9. PubMed ID: 18566243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization.
    Casas A; Fukuda H; Di Venosa G; Batlle AM
    Br J Dermatol; 2000 Sep; 143(3):564-72. PubMed ID: 10971330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma.
    Casas A; Fukuda H; Meiss R; Batlle AM
    Cancer Lett; 1999 Jul; 141(1-2):29-38. PubMed ID: 10454240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies.
    Perotti C; Fukuda H; DiVenosa G; MacRobert AJ; Batlle A; Casas A
    Br J Cancer; 2004 Apr; 90(8):1660-5. PubMed ID: 15083200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
    Loh CS; MacRobert AJ; Bedwell J; Regula J; Krasner N; Bown SG
    Br J Cancer; 1993 Jul; 68(1):41-51. PubMed ID: 8318419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
    Curnow A; Perry A; Wood M
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyrin profile in four human cell lines after supplementation with 5-aminolaevulinic acid and its methyl ester.
    Barron GA; Valentine R; Moseley H; Brancaleon L; Hill C; Woods JA
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):654-63. PubMed ID: 24284124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.
    Hinnen P; de Rooij FW; van Velthuysen ML; Edixhoven A; van Hillegersberg R; Tilanus HW; Wilson JH; Siersema PD
    Br J Cancer; 1998 Sep; 78(5):679-82. PubMed ID: 9744510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.
    Juzeniene A; Juzenas P; Ma LW; Iani V; Moan J
    Br J Dermatol; 2006 Oct; 155(4):791-9. PubMed ID: 16965430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.